Myeloid cells, which consist of granulocytes, monocytes, and their precursors, account for approximately half of the hematopoietic cells in human and murine marrow. To identify the transcriptional events which initiate myeloid differentiation, we are investigating the regulation of genes expressed in immature myeloid cells. Myeloperoxidase (MPO) and neutrophil elastase (NE) are microbicidal proteins present in the primary granules of myeloid cells (32, 48) . These proteins, and their cognate mRNAs, are not found in other cell lineages (48, 51) , and transcriptional regulation is in part responsible for their lineage-specific expression (15, 39, 62) . MPO and NE are early markers of both the granulocytic and monocytic lineages (14, 38) . Human MPO protein has been detected even in myeloid progenitor cells (46) . The murine and human MPO genes have been cloned and sequenced (17, 55) . They both lack a TATAA homology. The murine MPO gene initiates transcription from two major sites separated by approximately 400 bp (15) . The sequences between, and those 1,200 bp upstream of, these sites are 60% homologous to the region of the human MPO gene located PEBP2/CBF REGULATES MYELOID GENES 5559 ens the affinity of a subunits for DNA (35, 57) . Alternatively spliced forms of each of the aL subunits and of the L subunit have been detected (4, 35, 36, 57) .
The PEBP2cx subunits each contain a region homologous to the Drosophila Runt protein (21) . This 127-amino-acid Runt homology domain is required for DNA binding and heterodimerization (26, 36) . The consensus DNA-binding site for PEBP2atA is 5'-PuACCPuCA-3' (20) , and the consensus DNA-binding site for PEBP2aB is 5'-ACCPuCA-3' (26) . The a subunits will not bind the related DNA element 5'-1TC CACA-3', which is found at the core of the simian virus 40 enhancer and interacts with C/EBPs, AP-3, and TEF-2 (9, 18, 30) .
The human PEBP2cxB gene, also termed the AML1 gene, is located at the breakpoint of t(8;21)(q22;q22), which is associated with some cases of FAB M2 acute myeloid leukemia (29) . These leukemic cells produces a fusion transcript, AMLl-ETO (12, 28) . The AML1 gene is also involved in t(3;21)(q26;q22), which is associated with some cases of therapy-associated myeloid leukemia and chronic myeloid leukemia blast crisis, and produces an AMLI-EAP (34) or AMLl-Evil (27) (24) . Our findings suggest that some or all of the oncoproteins expressed as a result of these chromosomal abnormalities could impair myeloid differentiation through inhibition of PEBP2/CBF function in leukemic cells.
MATERIALS AND METHODS
Cells and transfection. 32D c13 cells (53) were maintained at 37°C in a 5% CO2-Iscove modified Dulbecco medium supplemented with 10% heat-inactivated fetal bovine serum and 5% WEHI-3B supernatant as a source of interleukin 3 (58) . For induction of granulocytic differentiation, cells were washed twice with phosphate-buffered saline (PBS) and placed in Iscove modified Dulbecco medium-10% heat-inactivated fetal bovine serum supplemented with 1,000 U of granulocyte colony-stimulating factor (G-CSF) (Amgen) per ml. Mouse L cells (22) were maintained in Dulbecco modified Eagle medium-10% fetal bovine serum.
Transient transfection of 32D c13 cells and L cells, luciferase assay, and chloramphenicol acetyltransferase (CAT) assay were accomplished as described previously (47) .
Nuclear extracts with DFP. Nuclear extracts were prepared by the method of Dignam et al. (11) as modified by Lee et al. (23) . Cells (2 x 108) were washed twice with PBS and incubated on ice in 5 ml of buffer A containing 5 mM diisopropylfluorophosphate (DFP) (Sigma) for 15 min. The cells were then resuspended in 2 of ml buffer A-0.5 mM DFP-0.75% nonfat dried milk (Carnation)-0.01% Nonidet P-40-0.5 mM dithiothreitol-0.4 mM phenylmethylsulfonyl fluoride-2 mM benzamidine-0.5 mM spermidine-10 ,ug of leupeptin per ml-1 ,ug of pepstatin A per ml-1 ,ug of antipain per ml-1 ,ug of chymostatin per ml-2 ,ug of soybean trypsin inhibitor per ml-10 jig of aprotinin per ml. Cells were then lysed by 10 (13) . Filters were washed to a stringency of 65°C in 0.1X SSC-0.05% SDS for 30 min and exposed to autoradiography film at -70°C. The murine P5-tubulin probe has been described previously (15) . Murine NE mRNA was detected by using a 400-bp genomic probe containing murine NE exon 4. A 1.8-kb EcoRI fragment containing the murine PEBP2otB cDNA (4) and a 2.5-kb EcoRI fragment containing most of the murine PEBP2otA cDNA (36) were used as probes as well.
Nucleotide sequence accession number. The GenBank accession number for murine NE is U04962.
RESULTS
The MyNFls are intact in DFP nuclear extracts. We had previously found that the ubiquitious transcription factor USF was intact in uninduced 32D c13 or L-cell extracts prepared without DFP. However, USF was completely degraded in 4-day-induced 32D c13 extracts prepared similarly (47) , likely because of abundant proteases in their primary granules. To improve protein integrity, we introduced three modifications into our nuclear extraction procedure. First, intact cells were incubated with DFP, a very strong covalent serine protease inhibitor which can traverse cell membranes (60) . DFP was also included in the cell lysis buffer. Second, nonfat dried milk was included in the cell lysis buffer as a protease "sink" (10) . Third, extracts were frozen without dialysis. Extracts from uninduced 32D c13 cells and from 32D c13 induced to the promyelocytic stage of granulocyte differentiation by exposure Integrity of MyNFIs and USF in 32D c13 cell DFP nuclear extracts. Nuclear extracts were prepared from uninduced (32D-IL3) and 4-day-induced (32D-G4) 32D c13 cells as described previously (47) with the following modifications: cells were treated with 5 mM DFP prior to lysis, 0.5 mM DFP and 0.75% nonfat dried milk were included in the cell lysis buffer, and extracts were not dialyzed. The integrity of the MyNFIs and of USF in these extracts and in an L-cell extract produced as described previously (47) was assessed by EMSA.
to G-CSF for 4 days (53) were prepared in this manner. The integrity of USF and of the MyNFls in these extracts and in an L-cell nuclear extract prepared without these modifications was determined by EMSA ( Fig. 1) . USF was intact in the L-cell and uninduced 32D c13 cell extracts and was approximately 60% intact in the induced 32D c13 cell extract. The MyNFly species previously noted in induced 32D c13 extracts (47) was no longer observed. Instead, now both MyNFlo and MyNF1l levels increased during early 32D c13 cell differentiation, whereas previously only MyNF13 had been noted to increase (47) . Thus, MyNFlo was not degraded to MyNFly in DFP nuclear extracts.
The MyNFI-binding site fits the PEBP2/CBF consensus. The MyNFl-binding site fits the viral enhancer core motif 5'-(T/A)(T/A)(T/A)CCACA-3' present in a variety of mammalian viruses (59) . One group of enhancer core-binding proteins, typified by the C/EBPs, prefers the site 5'-TTC CACA-3' (1, 18) . However, a C/EBP oligonucleotide did not compete for MyNF1 binding (47) . Also, the murine MPO MyNFl-binding site is 5'-AACCACA-3', which better fits the consensus for the PEBP2/CBF family, 5'-PuACCPuCA-3'. To further test the hypothesis that the MyNFls are PEBP2/CBFs, we prepared a murine MPO-derived oligonucleotide in which the centrally located MyNFI-binding site had been changed to 5'-GACCGCA-3', which still conforms to the PEBP2/CBF consensus. We also prepared a similar oligonucleotide in which the MyNFl-binding site had been changed to 5'-TTCCACA- 3', fitting the C/EBP consensus. These two oligonucleotides, the wild-type oligonucleotide, and a mutant oligonucleotide with site 5'-TAGCACA-3' were labelled to similar specific activities and used in an EMSA with extracts from 4-dayinduced 32D c13 cells (Fig. 2a) . Only the oligonucleotides containing enhancer core sites fitting the PEBP2/CBF consensus bound MyNFla and MyNFl,. To confirm these differences in affinity, an EMSA competition experiment was performed (Fig. 2b) . The ability of a 10-, 50-, or 200-fold excess of each unlabelled oligonucleotide to compete for MyNF1 binding to 1 ng of radiolabelled wild-type murine MPO oligonucleotide was determined. A 10-fold excess of the two oligonucleotides with DNA elements which fit the PEBP2/CBF consensus prevented binding almost completely, whereas even a 50-fold excess of the other two oligonucleotides only perturbed binding mildly.
These assays show that the MyNFls bind in vitro to sites which fit the PEBP2/CBF consensus. To determine whether the MyNFls bind and function through the same sites in vivo, each of the four oligonucleotides employed for Fig. 2 was assessed for its ability to stimulate a minimal MPO-thymidine kinase (TK) promoter in induced 32D c13 cells. A single copy of each oligonucleotide was inserted in the forward orientation upstream of base -241 in pMPOH(A-552/-241)TKLUC. This plasmid lacks the MyNFl-binding site and several surrounding elements that are active only in myeloid cells. It retains an element located between positions -71 and 0 which was equally active in 32D c13 cells and L cells (47) and also contains a TATAA homology in the TK segment. We employed this method because the wild-type murine MPO oligonucleotide, containing an MyNFl-binding site, stimulated pMPOH(A-552/-241)TKLUC 30-fold but stimulated pTKLUC only 4-fold (47) . Apparently, the MyNFls are optimally active in cooperation with additional factors. Also, in 32D c13 cells the activity of pTKLUC was often near the limits of detection, whereas pMPOH(A-552/-241)TKLUC was ninefold more active (47) . We found that the two oligonucleotides containing sites which fit the PEBP2/CBF consensus consistently increased the activity of pMPOH(A-552/ -241)TKLUC 20-to 40-fold, whereas the other two oligonucleotides were not stimulatory (Fig. 2c) . Of note, the 5'-GACCGCA-3' site was about twice as active in vivo as the 5'-AACCACA-3' site and bound the MyNFis with about twice the affinity in vitro as well (Fig. 2a) .
To verify that PEBP2/CBF can bind the wild-type murine MPO-derived oligonucleotide, the ability of an in vitro-transcribed and -translated Runt homology domain derived from PEBP2atB to bind this oligonucleotide was assessed (Fig. 3a) . Specific binding at the PEBP2/CBF site was observed.
The MyNFls supershift with PEBP2/CBF a subunit antiserum. The oligonucleotide containing a centrally located murine MPO MyNFl-binding site was radiolabelled and incubated with extracts from 4-day-induced 32D c13 cells. For supershift assay, the extracts were preincubated for 30 min with 1 or 2 [il of a rabbit polyclonal antiserum raised against a 17-amino-acid peptide derived from the N terminus of PEBP2acB coupled to keyhole limpet hemocyanin (26) . To block the antiserum, 4 jig of the specific peptide was added to the extract prior to antiserum addition (Fig. 3b) . Inclusion of the PEBP2atB antiserum disrupted or shifted the MyNF1p species completely, and 60 to 80% of the MyNFla species were disrupted or shifted as well. A doublet, likely containing supershifted MyNFla and MyNFl1, was evident near the top of the lanes in which antiserum, but no peptide, was added. This doublet is better seen in Fig. 3c and in Fig. 7c A similar supershift assay was also carried out with extracts from uninduced 32D c13 cells (Fig. 3c) . Again the MyNFlo and MyNF1lB species were supershifted by the PEBP2otB antiserum, the specific peptide blocked this reaction, and normal rabbit serum did not produce a supershift of the MyNFIs. Of note, the more slowly migrating doublet observed with uninduced, but not induced, extracts (Fig. 1 ) did not supershift with this antiserum, and neither did the minor species migrating just above MyNFlo. We previously found that nuclear extracts from SP2 lymphoid cells and MEL erythroid cells did not contain the MyNFIs but did contain species which migrate more slowly in a gel shift reaction with a PEBP2/CBF oligonucleotide (47) . These species also did not supershift with the PEBP2otB N-terminus antiserum (not shown).
Cloning the murine NE promoter. To obtain the gene encoding a second murine myeloid primary granule protein, we screened a BALB/c lambda genomic library with the human NE cDNA and obtained a clone with a 19-kb insert. The insert was subcloned, and fragments containing exons were identified by Southern blotting with the human NE cDNA as probe (not shown). The five exons were sequenced in their entirety, along with some neighboring DNA segments. The predicted amino acid sequence of the mature murine NE protein is 81% identical and 90% homologous to that of human NE. A search of the GenBank and EMBL databases revealed that the next-most-related protein-coding segment is that of human azurocidin, another serine protease (2) , which has 46% identity and 56% homology.
To further verify the identity of the murine NE genomic clone, mRNA was prepared from uninduced 32D c13 cells and from cells induced with G-CSF for 4, 7, or 10 days. These mRNAs were subjected to Northern blotting, and the filter was probed sequentially for murine NE and for murine 15 10 -dayinduced (G4, G7, and GIO, respectively) 32D c13 cells were subjected to Northern blotting and probed sequentially for these two mRNAs. The position of 18S rRNA is indicated for each blot. (Fig. 4) . A 1.3-kb murine NE mRNA was observed in induced, but not uninduced, 32D c13 cells. The human NE mRNA is also 1.3 kb (49). The expression of murine NE mRNA decreases as 32D c13 cells mature from the promyelocyte stage (day 4) to the neutrophil stage (day 10), as does the expression of the two 35-tubulin mRNAs.
Finally, significant homologies in the human and murine NE 5'-flanking regions were also noted (Fig. 5) . Within the first 100 bp, both the human and murine genes contain TATAA homologies, as well as potential binding sites for members of the Ets and C/EBP families and also for c-Myb. The murine NE gene also contains an element, 5'-GGCCACA-3', which differs from the PEBP2/CBF consensus, 5'-PuACCPuCA-3', only by an A-to-G transition at the second position. The element 5'-AGCCGCA-3', present in the enhancer core simian immunedeficiency virus, contains the same A-to-G transition and has been shown to bind PEBP2/CBF (56).
The murine NE promoter contains several functional elements. A DNA fragment containing 1,800 bp of murine NE 5'-flanking sequences and the entire 5'-untranslated region was linked upstream of the luciferase cDNA to create pNELUC. In initial experiments we found that deletion of pNELUC to position -1,000, -180, or -103 was of minimal functional consequence (not shown). Clustered point mutations were therefore introduced at six locations between positions -107 and -42 in pNELUC. The activities of pNELUC and of a 5'-deletion series of pNELUC with endpoints -103, -91, -79, -66, -55, and -42 were assessed in induced 32D c13 cells by transient transfection (Fig. 6a) . The activities of the six clustered point mutations in uninduced and induced 32D c13 cells were evaluated (Fig. 6b) .
Deletion to position -91 was of minimal consequence, and mutation of bases -107 to -103 or -95 to -91 was of no consequence, in induced 32D Deletion to position -55 removed a potential C/EBPbinding element and decreased NE promoter activity an additional sevenfold, although this finding, and the result of further deletion to position -42, is difficult to evaluate because the resulting luciferase activities approached background levels. Disruption of the C/EBP-binding site with clustered mutations at positions -61 to -55 decreased NE promoter activity more than 30-fold, and disruption of the c-Myb site, in pNE(-47/-42)LUC, decreased activity 5-fold. Thus, the conserved segment of the murine NE 5'-flanking region contains four functional elements.
Mutation of the PEBP2/CBF site increased pNELUC activity in L cells (one-, three-, or fivefold in three experiments). Mutation of the murine MPO PEBP2/CBF site had no effect on murine MPO proximal enhancer activity in L cells, and MyNFIs were not detected in L-cell nuclear extracts (47) .
Of note, pNELUC was 7-fold more active in induced, compared with uninduced, 32D c13 cells, pNE(m-107/ -103)LUC was 11-fold induced, and pNE(m-95/-91)LUC was 5-fold induced. However, the activity of pNE(m-61/ -55)LUC, which lacks a C/EBP site, was not induced by G-CSF. The activities of pNE(m-85/-79)LUC, pNE(m-69/ -66)LUC, and pNE(m-47/-42)LUC increased two-to threefold. These data suggest that integrity of the C/EBP site is critical for pNELUC induction and that integrity of the PU.1, PEBP2/CBF, and c-Myb DNA elements is required for optimal induction as well. Perhaps these four factors form a complex on the promoter which stimulates binding of the basal transcription machinery at the TATAA box. This model may account for our observation that the contribution of each DNA element to overall promoter function varied somewhat between experiments, increasing the standard errors for the activities of some of the constructs. (4) 93 (76) 19 (13) 18 (107) 1.6 (2) 3.6 (6) 13 (8) 34 (35) 2.3(2.5) 2.1(2.0) 6.7 (4) 19 (21 
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E32D(G2) FIG. 6 . Activity of murine NE (mNE) 5'-deletion and clustered point mutation constructs in 32D c13 cells. (a) Ten micrograms of each diagrammed plasmids, containing 5' murine NE promoter deletions, was cotransfected with 0.5 ,ug of pMSVCAT into 32D c13 cells, which were then cultured in the presence of G-CSF. Cell extracts were assayed for luciferase and CAT activities 2 days later. The ratio of luciferase to CAT activities was set at 100% for pNELUC in each experiment. The average activity of each construct, in five experiments, is shown. Each average is also shown numerically above each bar, along with the standard error in parentheses. (b) Fifteen micrograms of each diagrammed plasmid, containing clustered point mutations introduced into the murine NE promoter segment in pNELUC, was cotransfected with 0.5 ,ug of pMSVCAT into 32D c13 cells. These cultures were then split between interleukin 3-and G-CSF-containing media. Two days later, extracts were assayed for luciferase and CAT activities. The activity of pNELUC in induced 32D c13 cells was set at 100% in each experiment. The average activity of each construct, in at least four experiments, is shown.
The murine NE promoter element at positions -72 to -66 binds PEBP2/CBF. An oligonucleotide corresponding to bp -81 to -57 of the murine NE promoter was prepared. This oligonucleotide contains a centrally located, near-consensus PEBP2/CBF site and includes a portion, but not all, of the adjacent PU.1 and C/EBP sites. Similar oligonucleotides, containing either a disrupted PEBP2/CBF element or a consensus PEBP2/CBF site, were also prepared. These oligonucleotides and a murine MPO-derived oligonucleotide containing a consensus PEBP2/CBF element were labelled to similar specific activities and used in an EMSA with nuclear extracts from 4-day-induced 32D c13 cells (Fig. 7a) . The murine NE oligonucleotide, but not the variant with a disrupted PEBP2/ CBF site, weakly bound both MyNF1ox and MyNF13, and no other bands were evident. An additional oligonucleotide in which the murine NE PEBP2/CBF site was disrupted by introduction of an XhoI site, as was done for the functional studies, also did not bind the MyNFls (not shown). Conversion of the near-consensus PEBP2/CBF site to a consensus site, in the context of the murine NE oligonucleotide, increased binding of these factors to a level similar to that obtained with the murine MPO oligonucleotide. Flanking sequences appear not to influence the affinity of the MyNFls for the 7-bp PEBP2/CBF site. To confirm these differences in affinity, an EMSA competition experiment was performed (Fig. 7b) . The ability of a 10-or 50-fold excess of each unlabelled oligonucleotide to compete for MyNFI binding to 1 ng of radiolabelled murine NE oligonucleotide was determined. A 10-fold excess of each of the three oligonucleotides with DNA elements which fit, or nearly fit, the PEBP2/CBF consensus prevented binding almost completely, whereas even a 50-fold excess of the mutant murine NE oligonucleotide only perturbed binding mildly.
The wild-type murine NE and MPO oligonucleotides were employed in a supershift assay in the same experiment (Fig.  7c) . Binding of MyNFl to either oligonucleotide was disrupted or shifted completely, whereas binding of MyNFlox was disrupted or shifted only partially, by inclusion of anti-PEBP2/ CBF ot subunit antiserum. A doublet containing these supershifted species was noted near the top of the gel. Finally, the specific peptide again prevented interaction between the antiserum and the MyNFls. 32D c13 cells contain both PEBP2aB and PEBP2aA mRNAs. As discussed, the antiserum employed for the supershift assay would likely recognize both PEBP2aB and PEBP2oA. We and others are attempting to obtain specific, high-affinity antisera that will recognize these polypeptides. To determine whether 32D c13 cells contain mRNAs encoding one or both PEBP2ao, we prepared poly(A)+ mRNAs from uninduced, 3-day-induced, and 6-day-induced 32D c13 cells and subjected these mRNAs to Northern blotting (Fig. 8) .
PEBP2aB mRNAs of 6.2 and 2.1 kb were detected, as were 7.4-and 6.3-kb PEBP2otA mRNAs. These mRNAs correspond in size to analogous mRNAs detected in other cell types (4, 36) .
DISCUSSION
In a report of an initial investigation of the transcriptional regulation of the murine MPO gene, we described a 414-bp proximal enhancer (47) . This enhancer contains several positively acting functional DNA elements. Mutation of one element, 5'-AACCACA-3' was found to markedly diminish enhancer function, and the element was shown to bind a set of myeloid-restricted factors, MyNFla and MyNF13. This DNA element is also present at the analogous location in the human MPO gene. Optimum function of the factor interacting with this element depended on the presence of neighboring DNAbinding elements (47) . We (14) . Striking conservation was noted within the proximal 100 bp of the human and murine NE 5'-flanking regions. Four DNA elements functional in induced 32D c13 cells were described. One of the elements is predicted to bind a member of the Ets family. The Ets family member PU.1 has been shown to regulate the CD11b and macrophage colonystimulating factor receptor genes in monocytes (37, 63) , and it may regulate the CD18 and CD11a genes as well (6, 44) . The murine NE PU.1 site fits the consensus sequence 5'-RRR GAGGAAG-3' noted to be present in several genes expressed in myeloid cells (44) , although the active CDllb and macro-VOL. 14, 1994 . phage colony-stimulating factor receptor PU.1 sites differ from this consensus (37, 63) . The murine MPO proximal enhancer contains this element as well, although its function has not been evaluated by point mutation. The Ets family member Ets-1 was recently shown to cooperatively bind DNA with PEBP2/CBF, and there are functional Ets and PEBP2/CBF sites in several viral enhancers (reference 61 and references therein).
The functional murine NE C/EBP site fits the consensus 5'-T(T/G)NNGNAA(T/G)-3' (1) . Interestingly, conservation between the human and murine NE C/EBP sites extends precisely over this 9-bp site. Of note, this site differs from the CCAAT site known to bind ubiquitously expressed factors (7) . A C/EBP has been shown to cooperate with c-Myb to activate the mim-1 and lysozyme genes in immature avian myeloid cells (33) , and a C/EBP activates the G-CSF gene in monocytes as well (31) . Interestingly, integrity of the C/EBP site was most critical for increased pNELUC activity during 32D c13 cell differentiation, and the levels of C/EBPa, C/EBP,B, and C/EBP,y increase during early 32D c13 granulopoiesis (43) .
Integrity of the segment 5'-CAACGG-3', which is present in both the human and murine NE promoters and fits the c-Myb consensus, 5'-(T/C)AAC(G/T)G-3' (5) , is required for optimal murine NE promoter function as well. The murine MPO gene has an element 5'-CAACTG-3' just upstream of the PEBP2/ CBF-binding site, and mutation of this element decreased murine MPO proximal enhancer function fivefold (47) . The corresponding segment of the human MPO gene has the sequence 5'-TAACTG-3', which also fits the Myb consensus. Integrity of adjacent c-Myb-and PEBP2/CBF-binding sites is critical for activity of the TCR8 enhancer (16) . Interestingly, the murine MPO PEBP2/CBF site was able to stimulate a hybrid murine MPO-TK promoter 20-fold in the absence of the adjacent c-Myb site (47) (Fig. 2C ), suggesting differences in the makeups of the murine MPO and the TCR8 enhancers.
The murine, but not the human, NE promoter contains an element, 5'-GGCCACA-3', which matches the PEBP2/CBF consensus, 5'-PuACCPuCA-3', except for an A-to-G transition at position 2. As previously described (56), we found that an element with this transition will bind PEBP2/CBF, albeit weakly compared with a consensus site. Mutation or removal of the PEBP2/CBF element in the murine NE promoter impaired promoter function approximately fourfold in induced 32D c13 myeloid cells. Thus, PEBP2/CBF binds and activates the murine MPO proximal enhancer strongly (30-fold) and binds and stimulates the analogous region of the murine NE modestly. Also, PEBP2/CBF optimally activates both murine MPO and NE only when neighboring cis-regulatory elements are present.
The above discussion leads to the model that genes expressed specifically in immature myeloid cells are regulated by some combination of a PEBP2/CBF, Myb or a Myb-related protein, a C/EBP, and PU.1 or another Ets family member.
The contribution of each of these factors to regulating other early myeloid genes, as well as more distal regions of the murine and human NE genes, will need to be determined to test this model. The mim-1 and lysozyme genes were activated in nonmyeloid cells transfected with Myb and C/EBP expression vectors (33) , and the macrophage colony-stimulating factor receptor was activated by a PU.1 expression vector (63) in nonmyeloid cells as well. We cotransfected pMPOHTKLUC and pNELUC with expression vectors for PEBP2aB and PEBP2I/CBFP in 32D c13 cells and in L cells. No consistent trans-activation was found in either cell type. Presumably, L cells require expression of additional myeloid activators to allow MPO or NE enhancer function, and 32D c13 cells already have abundant endogenous PEBP2/CBFs, preventing additional trans-activation. Experiments are in progress to identify the additional factors which cooperate with PEBP2/CBFs to regulate the murine MPO and NE proximal regulatory regions. Perhaps we will then be able to identify a combination of these regulators which is sufficient to activate both the MPO and NE genes in nonmyeloid cells and which allows cooperative binding to enhancer fragments in vitro. Of note, both PEBP2cxA and PEBP2aoB, the ao subunits of two PEBP2/CBF family members, were recently shown to trans-activate a T-cell receptor enhancer in two heterologous cell types containing reduced levels of endogenous PEBP2/CBFs (3, 26a) .
The distribution of PEBP2/CBF proteins in tissue has not been established. PEBP2/CBF gel shift activities were detected in extracts from myeloid and lymphoid cells but not in liver, kidney, lung, or heart extracts (50, 56), although multiple cell lines contain these activities (26, 47) . We demonstrated that 32D c13 cells contain mRNAs corresponding to two PEBP2/ CBF at subunit family members, PEBP2aA and PEBP2aB.
Development of additional antiserum reagents will be necessary to determine whether the two MyNF1 gel shift bands contain one or both of these PEBP2/CBFs.
Finally, it is provocative that PEBP2/CBF regulates the murine MPO 
